7Baggers

We provide you with 20 years of free, institutional-grade data for VRCA stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of VRCA. Explore the full financial landscape of VRCA stock.

Reported DateCIKTickerType
2023-11-091660334VRCA10-QUrl
2023-08-081660334VRCA10-QUrl
2023-05-091660334VRCA10-QUrl
2023-03-061660334VRCA10-KUrl
2022-11-071660334VRCA10-QUrl
2022-08-111660334VRCA10-QUrl
2022-05-091660334VRCA10-QUrl
2022-03-021660334VRCA10-KUrl
2021-11-121660334VRCA10-QUrl
2021-08-101660334VRCA10-QUrl
2021-05-071660334VRCA10-QUrl
2021-03-171660334VRCA10-KUrl
2020-11-091660334VRCA10-QUrl
2020-08-051660334VRCA10-QUrl
2020-05-071660334VRCA10-QUrl
2020-03-131660334VRCA10-KUrl
2019-11-061660334VRCA10-QUrl
2019-08-071660334VRCA10-QUrl
2019-05-071660334VRCA10-QUrl
2019-03-071660334VRCA10-KUrl
2018-11-071660334VRCA10-QUrl
2018-08-071660334VRCA10-QUrl
2018-05-221660334VRCAS-1Url

Verrica Pharmaceuticals Inc
(NASDAQ:VRCA) 

VRCA stock logo

Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; which has completed phase II clinical trial fo...

Founded: 2013
Full Time Employees: 17
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
The information provided in this report about VRCA stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.